secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2022-09-09T23:59:59+00:00
Accession:  0001185185-22-001082
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC shareholders elect directors, ratify auditor, approve 3M share grant
------------------------------------------------------------------------

- Ram Mukunda, James Moran elected Class C directors until 2025; Claudia Grimaldi elected Class A director until 2023.
- Ratified Manohar Chowdhry & Associates as independent auditor for fiscal 2023.
- Approved grant of 3,000,000 common shares to employees, advisors, directors under performance/vesting metrics.
- Total shares voted: 35,103,116 (67.40% of outstanding); broker non-votes 11,861,428.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/0001185185-22-001082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/indiaglob20220909_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-22-001082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer